On (b)(6) 2023, impulse dynamics received an fda medwatch alert that an optimizer implantable pulse generator (ipg) device., "was part of a system revision due to infection.There were no additional adverse patient effects reported.The device was explanted." further investigation revealed this report is tied to a complaint received on (b)(6) 2023 of a patient that was initially implanted with an optimizer smart mini ipg device on (b)(6) 2023.The patient was admitted to the hospital on (b)(6) 2023 with bacteremia; a pocket infection was suspected.It was also reported that the patient had been experiencing lower than normal cardiac contraclility modulation (ccm) therapy delivery.Fluoroscopy performed on (b)(6) 2023 confirmed ipg lead dislodgement, causing the low therapy delivery.The smart mini ipg and connected leads were explanted on (b)(6) 2023.The ipg and leads were discarded after removal.A review of the device history record (dhr) of the ipg was conducted and found no anomalies.The device was sterilized per procedure and implanted within the required expiry period.A review of the device registration record revealed no indication that a concomitant device was also implanted in the patient.The suspected cause of the lead dislodgement is improper surgical placement and/or user technique; however, the complaint remains under investigation.
|